Table 1

Demographic data, clinical characteristics and treatment of the patients with confirmed and clinical-COVID-19

Confirmed COVID-19Clinical-COVID-19
Patients, n (% of total cohort)4 (2.5)8 (5)
Female, n (% of the group)4 (100)7 (87.5)
Median age in years (range)52.5 (27–53)34 (25–59)
Median disease duration in years (range)21.5 (14–29.75)11 (5–20)
Comorbidities, n (%)
 Hypertension2 (50)2 (25)
 Diabetes0 (0)0 (0)
 Cardiovascular disease1 (25)0 (0)
 Obesity0 (0)0 (0)
Smoking, n (%)
 Active1 (25)0 (0)
 Previous0 (0)2 (25)
Therapy, n (%)
Hydroxychloroquine3 (75)7 (87.5)
Glucocorticoids (≤7.5 mg/day)1 (25)3 (37.5)
Mycophenolate3 (75)3 (37.5)
Azathioprine0 (0)1 (12.5)
Cyclosporine0 (0)1 (12.5)
Symptoms, n (%)
 Fever3 (75)8 (100)
 Non-productive cough2 (50)8 (100)
 Sputum production1 (25)4 (50)
 Rhinorrhea3 (75)4 (50)
 Sore throat2 (50)4 (50)
 Fatigue2 (50)6 (75)
 Arthromyalgia2 (50)5 (62.5)
 Anosmia/dysgeusia2 (50)4 (50)
 Dyspnoea1 (25)6 (75)
 Headache2 (50)6 (75)
 Diarrhoea2 (50)3 (37.5)
 Nausea/vomiting1 (25)2 (25)
Chest X-ray performed, n (%)2 (50)2 (25)
Chest X-ray pathological findings, n (%)1 (25)0 (0)
ICU admission, n (%)1 (25)0 (0)